1. Home
  2. CXAI vs CGTX Comparison

CXAI vs CGTX Comparison

Compare CXAI & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CXAI
  • CGTX
  • Stock Information
  • Founded
  • CXAI N/A
  • CGTX 2007
  • Country
  • CXAI United States
  • CGTX United States
  • Employees
  • CXAI N/A
  • CGTX N/A
  • Industry
  • CXAI EDP Services
  • CGTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CXAI Technology
  • CGTX Health Care
  • Exchange
  • CXAI Nasdaq
  • CGTX Nasdaq
  • Market Cap
  • CXAI 33.9M
  • CGTX 30.0M
  • IPO Year
  • CXAI N/A
  • CGTX 2021
  • Fundamental
  • Price
  • CXAI $1.61
  • CGTX $0.64
  • Analyst Decision
  • CXAI
  • CGTX Strong Buy
  • Analyst Count
  • CXAI 0
  • CGTX 6
  • Target Price
  • CXAI N/A
  • CGTX $8.30
  • AVG Volume (30 Days)
  • CXAI 935.9K
  • CGTX 945.7K
  • Earning Date
  • CXAI 11-12-2024
  • CGTX 03-25-2025
  • Dividend Yield
  • CXAI N/A
  • CGTX N/A
  • EPS Growth
  • CXAI N/A
  • CGTX N/A
  • EPS
  • CXAI N/A
  • CGTX N/A
  • Revenue
  • CXAI $7,200,000.00
  • CGTX N/A
  • Revenue This Year
  • CXAI $3.86
  • CGTX N/A
  • Revenue Next Year
  • CXAI $100.00
  • CGTX N/A
  • P/E Ratio
  • CXAI N/A
  • CGTX N/A
  • Revenue Growth
  • CXAI N/A
  • CGTX N/A
  • 52 Week Low
  • CXAI $1.09
  • CGTX $0.34
  • 52 Week High
  • CXAI $7.07
  • CGTX $2.95
  • Technical
  • Relative Strength Index (RSI)
  • CXAI 46.28
  • CGTX 43.76
  • Support Level
  • CXAI $1.42
  • CGTX $0.60
  • Resistance Level
  • CXAI $1.63
  • CGTX $0.82
  • Average True Range (ATR)
  • CXAI 0.13
  • CGTX 0.06
  • MACD
  • CXAI -0.01
  • CGTX -0.02
  • Stochastic Oscillator
  • CXAI 31.15
  • CGTX 18.56

About CXAI CXApp Inc.

CXApp Inc is a workplace experience platform for enterprise customers. It is a SaaS product for enterprise organizations, distributing a mobile app to all employees within the organization. It includes a content management system (or CMS) so customers can adjust configurations for their workplace settings autonomously and spontaneously. Its technologies and solutions help enterprise customers deliver a comprehensive business journey in a work 'from anywhere' world for employees, partners, customers, and visitors. CXApp offers native mapping, analytics, on-device positioning (or ODP), and application technologies that bring people together.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: